Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
Abstract After publication of the original article [1], it came to the authors’ attention that a reference was omitted from the Background.
Main Authors: | Yuzhu Wang, Tao He, James G. Herman, Enqiang Linghu, Yunsheng Yang, François Fuks, Fuyou Zhou, Linjie Song, Mingzhou Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Clinical Epigenetics |
Online Access: | http://link.springer.com/article/10.1186/s13148-018-0467-2 |
Similar Items
-
Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth
by: Yuzhu Wang, et al.
Published: (2017-10-01) -
Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer
by: Hege Marie Vedeld, et al.
Published: (2018-05-01) -
Methylation of DIRAS1 promotes colorectal cancer progression and may serve as a marker for poor prognosis
by: Ruipan Zheng, et al.
Published: (2017-05-01) -
Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis
by: Jiaxin Liu, et al.
Published: (2021-06-01) -
Association of ZNF331 and WIF1 methylation in peripheral blood leukocytes with the risk and prognosis of gastric cancer
by: Chuang Nie, et al.
Published: (2021-05-01)